Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Spondylitis, Ankylosing 1Psoriasis 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Melanoma 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Gastritis, Atrophic 1Crohn Disease 1Colorectal Neoplasms 1Colitis, Ulcerative 1Carcinoma, Transitional Cell 1Cancer Care Recipient 1Cancer Awareness and Prevention Education 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Phlebotomy 1Methods 1Laparoscopy 1Interviews as Topic 1Infliximab 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1CT-P13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Crohn Disease × Educational Status × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡